Deutsche Bank
WINT

Deutsche Bank’s Windtree Therapeutics Inc WINT Stock Holding History

Deutsche Bank’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,236
Closed -$2K – 5490
2016
Q1 		$2K Buy
+1,236
New +$2.65K ﹤0.01% 5063
2015
Q3 		– Sell
-107
Closed -$1K – 5481
2015
Q2 		$1K Sell
107
-348
-76% -$4.89K ﹤0.01% 5298
2015
Q1 		$7K Sell
455
-112
-20% -$2.21K ﹤0.01% 4862
2014
Q4 		$9K Buy
567
+29
+5% +$638 ﹤0.01% 5753
2014
Q3 		$13K Sell
538
-120
-18% -$2.9K ﹤0.01% 5331
2014
Q2 		$16K Buy
658
+408
+163% +$10.4K ﹤0.01% 5385
2014
Q1 		$1K Buy
+250
New +$8.41K ﹤0.01% 5528

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Deutsche Bank's WINT Position: Q2 2017 in Review

Deutsche Bank sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 43,340 shares — an estimated $49K sold.

Deutsche Bank first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $2.6M in Q4 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Deutsche Bank reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Deutsche Bank sold 43,340 Windtree Therapeutics Inc shares in Q2 2017, an estimated $49K.
  • Deutsche Bank first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Deutsche Bank's Windtree Therapeutics Inc position peaked at $2.6M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Deutsche Bank's 13F filing for Q2 2017, filed 11 Aug 2017.